Testing indicates a new malaria vaccine could be effective in helping to combat the disease. From MSNBC:

An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world’s first shot against the deadly disease.

Final-stage trial data released on Tuesday showed it gave protection against clinical and severe malaria in five- to 17-month-olds in Africa, where the mosquito-borne disease kills hundreds of thousands of children a year.

Malaria has been a terrible scourge on humanity literally since the beginning of our species. While eradication efforts have significantly reduced the disease in the developed world, the disease still kills around a million people a year worldwide and sickens many more.

While the trial is not complete, and this would not be a complete cure, an effective vaccine could dramatically improve the lives of millions of people all over the planet.

Blogging about politics and public policy can be extremely depressing at times, so it is good to be reminded there is some really positive news in the world.  I may come across very pessimistic, but at heart I’m an extreme sci-fi reading techno-optimist. I’m so determined to fight corrupt policy, because I believe good policy can help enable our almost limitless potential for improvement.

Jon Walker

Jon Walker

Jonathan Walker grew up in New Jersey. He graduated from Wesleyan University in 2006. He is an expert on politics, health care and drug policy. He is also the author of After Legalization and Cobalt Slave, and a Futurist writer at http://pendinghorizon.com